Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

A comprehensive review of curcumin-based scaffolds in cartilage tissue engineering

Talouki PY., Tamimi R., Rudi SG.

Narrative Review on Osteoarthritis, Cartilage Damage, Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Stem Cell Res Ther (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41023741
PMCID
PMC12482016
DOI
10.1186/s13287-025-04672-0
Citations
5

Abstract (original English)

Articular cartilage's avascular and aneural nature severely limits its intrinsic regenerative capacity, making injuries and degenerative diseases like osteoarthritis a significant clinical challenge. This review comprehensively examines the paradigm shift towards regenerative medicine strategies, focusing on the integration of the natural polyphenol curcumin into advanced cartilage tissue engineering. While curcumin possesses potent multi-modal therapeutic properties-including anti-inflammatory, antioxidant, anti-catabolic, and chondroprotective effects-its clinical translation is hindered by poor bioavailability and rapid metabolism. We explore innovative biomaterial-based solutions to these limitations, detailing the development of sophisticated DDSs such as nanoparticles, hydrogels (e.g., chitosan, gelatin methacrylate), and synthetic scaffolds (e.g., PCL, PLGA) that enable targeted, sustained release. The review critically analyzes the transition from conventional surgical techniques to emerging therapies like MSC-based treatments, gene therapy, and 3D-bioprinted constructs. Furthermore, we synthesize compelling clinical evidence demonstrating that bioavailable curcumin formulations (e.g., Meriva ® , Theracurmin ® ) significantly improve pain, stiffness, and functional scores in OA and RA patients. By bridging cutting-edge biomaterial science with the ancient therapeutic wi

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cartilage, ArticularAnimalsHumansOsteoarthritisCurcuminTissue EngineeringRegenerative MedicineTissue Scaffolds

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research